Cargando…
Direct and Indirect Modulation of T Cells by VEGF-A Counteracted by Anti-Angiogenic Treatment
Vascular endothelial growth factor A is known to play a central role in tumor angiogenesis. Several studies showed that VEGF-A is also an immunosuppressive factor. In tumor-bearing hosts, VEGF-A can modulate immune cells (DC, MDSC, TAM) to induce the accumulation of regulatory T-cells while simultan...
Autores principales: | Bourhis, Morgane, Palle, Juliette, Galy-Fauroux, Isabelle, Terme, Magali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039365/ https://www.ncbi.nlm.nih.gov/pubmed/33854498 http://dx.doi.org/10.3389/fimmu.2021.616837 |
Ejemplares similares
-
Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodeling
por: Mougel, Alice, et al.
Publicado: (2022) -
Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015) -
Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
por: Mougel, Alice, et al.
Publicado: (2019) -
Control of the Immune Response by Pro-Angiogenic Factors
por: Voron, Thibault, et al.
Publicado: (2014) -
Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma
por: Oladejo, Mariam, et al.
Publicado: (2022)